‘Metamersion: Latent Spaces’ joins art, science and technology at the Champalimaud Warehouse

The second edition of Metamersion, the cycle of artistic, scientific, technological and therapeutic immersive events of the Champalimaud Foundation, launches on December 15th with the programme Latent Spaces, taking place at the Champalimaud Warehouse, in the former warehouses of DocaPesca, in Lisbon, in a location that is also in a latent phase, and where the first steps towards the creation of a centre dedicated to Human Neuroecology and Digital Therapeutics are being taken.

Hands-on course on Zebrafish Xenografts 2023 - 2nd edition

This course is promoted by Champalimaud Foundation's Fior Lab, integrated in the congento - Consortium for Genetically Tractable Organisms - initiatives.

The scientific programme will cover

- Protocols for preparation of human cancer cells for injection;
- Generation of zebrafish xenografts (microinjection in the perivitelline space);
- Metastatic assay;
- Protocols for immunofluorescence;
- Mounting xenografts for confocal imaging;
- Confocal session.

Venue

Champalimaud Center for the Unknown, Lisbon

10 November 2022

Portuguese consortium to receive 78 million euros funding from the Programa de Recuperação e Resiliência to develop “responsible” AI

For every argument that construes AI as essential, promising and transforming across nearly all industries, there are voiced concerns about this technology. Many people do not trust AI, claiming that intelligent machines will one day dominate humankind. But while this is a remote possibility, the harm that can be done to people (albeit mostly unintentionally) by deep learning algorithms is very tangible – and has already been known to occur in the real world.

04 November 2022

Work from Champalimaud Foundation Researcher Acknowledged by the Eppendorf & Science Prize for Neurobiology

After receiving her bachelor's degree in Biochemistry and a master's degree in Health Sciences from the University of Minho, which introduced her to the field of immunology, Cardoso embarked upon a PhD in the laboratory of Henrique Veiga-Fernandes at the Champalimaud Foundation to study the role of neuro-immune interactions in metabolism.

27 September 2022

The Champalimaud Foundation will host the Neuro, Digital & AI Innovation Summit

Organised by Broadreach Global with the European Brain Foundation (EBC), this summit will  bring together - in a collaborative, roundtable format - a highly diverse group of key opinion leaders, from  innovators, to decision-makers. 

26 September 2022

Female flies enter the ring of sexual competition

When it comes to sexual competition, males have the star role. Clashing bodies, locking horns, biting and kicking are all considered fair play. Since these behaviours are so salient and robust, most studies focus on male behaviour, leaving females aside. 
 

20 September 2022

Concurso CaixaResearch announces funding awardees: Leopoldo Petreanu among winners

The CaixaResearch Health Research Contest 2022 has selected 33 promising new biomedical and health projects promoted by research centres and universities in Spain and Portugal. Once again affirming that the “la Caixa” Foundation, in collaboration with BPI, supports projects of excellence that can have a positive impact on the health of citizens. 

Within this framework, it has allocated a total of 23.1 million euros to such projects – 20 Spanish and 13 Portuguese – that will be developed over the next three years. 

09 September 2022

Champalimaud Foundation researchers discover new tool for improving pancreatic cancer care

The statistics for pancreatic cancer are sobering. With a five-year survival rate of only 9%, incidence of the most common type, pancreatic ductal adenocarcinoma (PDAC), is growing and projected to be the second cause of cancer deaths by 2030. Surgery remains the most effective treatment, yet for 70-80% of patients, surgery is not a viable option. Understanding pancreatic cancer at the cellular and subcellular level is essential for developing therapies that can buy patients more time.
 

18 August 2022

Science Snapshot: (Re) Generating Neurons

To know more about this research:

Digest

Scientific Article

24 August 2022

Scientists from the Champalimaud Foundation discover how multiple myeloma cells disrupt immunity

One of the hallmarks of multiple myeloma (MM), a cancer of the bone marrow and one of the most frequent haematological cancers worldwide, is the disruption of the patients’ immune system, which allows the cancer to progress. Now, a study performed by Cristina João, who leads the Myeloma and Lymphoma Research Group at the Champalimaud Centre for the Unknown, and her colleagues, shows how so-called extracellular vesicles (EV’s) released by multiple myeloma cells can drive the disruption of the immune system.

Subscribe to Research Groups
Loading
Please wait...